Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine
Document Type
Abstract
Publication Date
11-1-2023
Keywords
oregon; chiles
Clinical Institute
Cancer
Clinical Institute
Neurosciences (Brain & Spine)
Specialty
Oncology
Specialty
Neurosciences
Recommended Citation
Meng, R; Redmond, Will; Bifulco, Carlo; Sanborn, Rachel; Bell, RB; Urba, Walter; Leidner, Rom; Piening, Brian; Fox, Bernard; and See full list of authors in comments, "Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine" (2023). Articles, Abstracts, and Reports. 8348.
https://digitalcommons.providence.org/publications/8348
Comments
Meng R, Moudgil T, Iwamoto N, Minegishi Y, Koguchi Y, Rajamanickam V, Christie T, Redmond WL, Bifulco C, Hilton T, Dowdell A, Jensen SM, Sanborn RE, Hu H-M, Bell RB, Urba WJ, Leidner RS, Ueda K, Shimada T, Piening B, Fox BA. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 148.